Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew J. Brenner, Jasgit Sachdev, Mitesh Borad, Yoon Koo Kang, Jay Stoudemire, Susan Smith, Andreas G. Bader, Sinil Kim, David S. Hong

Research output: Contribution to journalArticlepeer-review

417 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences